Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
2.510
-0.020 (-0.79%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $373.99 million as of September 6, 2024. Its market cap has increased by 20.91% in one year.
Market Cap
373.99M
Enterprise Value
566.22M
1-Year Change
20.91%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since June 21, 2018, Xeris Biopharma Holdings's market cap has decreased from $384.90M to $373.99M, a decrease of -2.84%. That is a compound annual growth rate of -0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 374.00M | 15.22% |
| Dec 29, 2023 | 324.60M | 79.44% |
| Dec 30, 2022 | 180.90M | -50.49% |
| Dec 31, 2021 | 365.40M | 51.62% |
| Dec 31, 2020 | 241.00M | 26.64% |
| Dec 31, 2019 | 190.30M | -46.35% |
| Dec 31, 2018 | 354.70M | -7.85% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 378.64M |
| G1 Therapeutics | 377.11M |
| Nkarta | 375.37M |
| C4 Therapeutics | 374.42M |
| Cerus | 374.30M |
| DocGo | 371.41M |
| Aldeyra Therapeutics | 364.25M |
| Anika Therapeutics | 363.41M |